IPP Bureau
IPCA Q4FY21 consolidated net profit slides QoQ to Rs. 161.34 Cr
By IPP Bureau - May 29, 2021
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
Zydus new initiative to safeguard patients against counterfeit drugs
By IPP Bureau - May 29, 2021
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr
By IPP Bureau - May 29, 2021
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
Glenmark Q4 FY 2020-21 revenue grows 3.3%; Net profit up 6.2%
By IPP Bureau - May 29, 2021
For the year ended March 31, 2021, consolidated revenue was at Rs. 10,943.9 crores as against Rs. 10,641 crores, recording an increase of 2.8% over the previous corresponding period
Zydus Cadila's COVID Vaccine in advance stage of trial; Q4 FY21 income up 3%
By IPP Bureau - May 28, 2021
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
TLC partners Strides to launch Mucormycosis drug in India
By IPP Bureau - May 28, 2021
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Lupin receives US $50 mn on achieving cancer milestone
By IPP Bureau - May 28, 2021
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
Remdesivir demand was exaggerated: Dr. Sharvil Patel
By IPP Bureau - May 28, 2021
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Bharat Biotech signs MoU with GCVC for COVID Vaccine
By IPP Bureau - May 28, 2021
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
Sun Pharma acquires rights for Oxra, Oxramet and Oxraduo from AstraZeneca
By IPP Bureau - May 28, 2021
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
By IPP Bureau - May 27, 2021
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
By IPP Bureau - May 27, 2021
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
Sun Pharma Q4 FY21 net profit up 124%
By IPP Bureau - May 27, 2021
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Pfizer registers Q4FY21net profit at Rs 100 Cr
By IPP Bureau - May 26, 2021
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
By IPP Bureau - May 26, 2021
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
